Skip to content

Adient ADNT Research and development costs reimbursed by customers

Research and development costs reimbursed by customers at other companies

BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$20.67M
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$4.59M-52.5%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$57.07M+12.2%
Hyliion logo
HyliionHYLN
$2.62M+450%
ACI Worldwide logo
ACI WorldwideACIW
$44.09M+13.3%
Nuvation Bio logo
Nuvation BioNUVB
$8.6M+359%

Other financials

Income statement

See full
Revenue$3.9B+7.0%
Gross profit$257.0M-1.5%
Net income$27.0M+108%
EPS (diluted)$0.34+109%

Balance sheet

See full
Cash & equivalents$831.0M+10.2%
Total debt$2.6B+0.3%
Total equity$1.7B+3.7%
Total assets$9.0B+5.2%

Cash flow

See full
Operating cash flow$81.0M
CapEx$73.0M+62.2%
Free cash flow$8.0M+109%

Valuation

See full
Market cap$1.59B+46.7%
Enterprise value$3.39B+14.7%
P/E38.8×
P/S0.1×0.0×

Profitability

See full
Gross margin6.4%0.0pp
Net margin0.3%+0.1pp
FCF margin1.8%+0.2pp

Returns & leverage

See full
Return on equity2.4%+1.3pp
Debt / equity1.5×-0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Adient in its filing.

Tagged under the XBRL concept adnt:ResearchAndDevelopmentExpenseRecovery.

The official record: Adient’s 10-K, filed November 18, 2025, on SEC EDGAR. View the filing →

Ask your AI about Adient's research and development costs reimbursed by customers.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Adient's research and development costs reimbursed by customers?
Adient (ADNT) reported research and development costs reimbursed by customers of $72M in Q3 2025.
How has Adient's research and development costs reimbursed by customers changed year-over-year?
Adient's research and development costs reimbursed by customers increased by 2.9% year-over-year, from $70M to $72M.
What is the long-term trend for Adient's research and development costs reimbursed by customers?
Over 2 years (2023 to 2025), Adient's research and development costs reimbursed by customers has grown at a 7.3% compound annual growth rate (CAGR), from $250M to $288M.
What does research and development costs reimbursed by customers mean?
The portion of research and development costs that is contractually reimbursed by customers, typically through specific development agreements or project-based arrangements. This metric helps clarify the net R&D burden on the company's income statement by accounting for external funding support.